ArticleEquine veterinary journal2026
Outbreak of poisoning by sodium hydrogen methylarsonate (MSMA)-an arsenic-based herbicide-in horses in Brazil.
Article in Equine veterinary journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundArsenic poisoning in horses is rarely reported in the literature. However, arsenic compounds can be present in rodenticides, pesticides, and herbicides, representing a potential source of accidental exposure for horses.
objectiveTo describe the epidemiological, clinical, and laboratory findings from a herd of 31 horses exposed to pasture treated with an overdose of sodium hydrogen methylarsonate, and to compare results in a group of horses exposed to the recommended dosage of the same product. STUDY
designObservational field study.
methodsThirty-one horses were evaluated after grazing on a pasture sprayed with 7.9 kg/ha of MSMA. Sixteen animals underwent clinical examination, haematological and biochemical analyses, anatomopathological evaluation, and toxicological analysis. Arsenic concentrations were determined in biological and environmental samples to confirm exposure. The findings were compared with data collected from a group of horses grazing a paddock treated with the recommended dose.
resultsThe outbreak had a morbidity rate of 45.2% (14/31), a mortality rate of 19.4% (6/31), and a case fatality rate of 42.9% (6/14). Toxicological analysis showed increased arsenic concentrations in biological and environmental samples, confirming the diagnosis of poisoning. Supportive therapy was administered until the definite diagnosis and recovery of the surviving horses. Animals in the comparative group remained clinically normal and showed low arsenic concentrations. MAIN LIMITATIONS: The observational nature of the study, the delayed initiation of monitoring, and prior therapeutic interventions limited the scope of clinical data. Moreover, the rarity of arsenic poisoning in horses and the paucity of reference data restricted interpretation.
conclusionsArsenic toxicosis in horses affects gastrointestinal, vascular, and renal systems. Diagnosis is supported by anatomopathological findings, biochemical alterations, and detection of arsenic in kidney, liver, and faecal samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.